Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of niclosamide ethanolamine salt in prevention and treatment of type 2 diabetic nephropathy

A technology for niclosamide ethanolamine salt and type 2 diabetes, which is applied in the application field of preparing medicines for preventing and treating type 2 diabetic nephropathy, can solve the problems of no research report on the efficacy of DN prevention and treatment, and achieves improvement of pancreatic pathological damage, reduction of Urinary albumin excretion rate and the effect of increasing serum insulin level

Active Publication Date: 2018-11-23
SHENZHEN TRADITIONAL CHINESE MEDICINE HOSPITAL
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the efficacy of NEN in the prevention and treatment of DN has not been reported yet.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of niclosamide ethanolamine salt in prevention and treatment of type 2 diabetic nephropathy
  • Application of niclosamide ethanolamine salt in prevention and treatment of type 2 diabetic nephropathy
  • Application of niclosamide ethanolamine salt in prevention and treatment of type 2 diabetic nephropathy

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0021] Embodiments of the present invention will be specifically described below in conjunction with the accompanying drawings.

[0022] Early DN mainly manifests as glomerular hyperfiltration and microalbuminuria, and its pathological changes are mainly glomerular and tubular basement membrane thickening and mesangial matrix increase. The pathogenesis of DN is still unclear, and treatment methods are scarce. The mTOR / 4E-BP1 signaling pathway plays an important role in cell growth and proliferation, and its dysregulation is closely related to cancer, diabetes, cardiovascular and nervous system diseases. Recent studies have shown that the overactivation of this pathway is closely related to the progression of DN. NEN is the ethanolamine salt form of niclosamide, which is mainly used for anti-parasitic infections. Recent studies have shown that this type of drug also has obvious anti-tumor effects. However, there is no research report on the efficacy of NEN in the prevention an...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
lengthaaaaaaaaaa
Login to View More

Abstract

Provided is a use of niclosamide ethanolamine salt in preparing medicine for preventing and treating type 2 diabetes. The niclosamide ethanolamine salt can reduce urinary albumin excretion rate of a type 2 diabetic db / db mice, improve pathological injury of glomeruli and renal tubular, and also has a protective effect on the liver.

Description

technical field [0001] The present invention relates to a new application of Niclosamide ethanolamine salt (NEN), more specifically, relates to the application of NEN in the preparation of drugs for preventing and treating type 2 diabetic nephropathy. Background technique [0002] Diabetic nephropathy (DN) is one of the most important microvascular complications of diabetes. With the rising incidence of diabetes, DN has surpassed glomerulonephritis-associated chronic kidney disease (CKD) and has become the leading cause of CKD . The onset of DN is insidious, and once it enters the stage of massive proteinuria, it will soon progress to end stage renal disease (ESRD). The main clinical manifestations of early DN are glomerular hyperfiltration and microalbuminuria. Renal hypertrophy is the main pathological feature at this stage, mainly manifested as glomerular hypertrophy, glomerular and tubular basement membrane thickening, and mesangial areas. Extracellular matrix depositi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/167A61P13/12A61P3/10
CPCA61K31/167
Inventor 孙惠力杜蘅韩鹏勋邵牧民郭岚
Owner SHENZHEN TRADITIONAL CHINESE MEDICINE HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com